Salvage therapy after two or more prior Helicobacter pylori treatment failures: The super salvage regimen

Helicobacter

Volumn 8, Issue 4, 2003, Pages 307-309

  Dore, Maria Pina ^a,c   Marras, Lea ^a   Maragkoudakis, Emmanouil ^a   Nieddu, Salvatore ^a   Manca, Alessandra ^a   Graham, David Y ^b   Realdi, Giuseppe ^a  

^a Università Degli Studi di Sabari   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; BISMUTH CITRATE; CARBON 13; CLARITHROMYCIN; IMIDAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG CAPSULE; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALVAGE THERAPY; SIDE EFFECT; SMOKING; STOMACH BIOPSY; TREATMENT FAILURE; UREA BREATH TEST;

ADULT; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; BISMUTH; BREATH TESTS; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; SALVAGE THERAPY; TETRACYCLINES; UREA;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 0042838044     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2003.00150.x     Document Type: Article

References (8)

1. Malfertheiner P, Megraud F, O'Morain C, et al. The European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2. Consensus Report Aliment Pharmacol Ther 2000;16:167-80.
2. Realdi G, Dore MP, Piana A, et al. Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies. Helicobacter 1999;4:106-12.
3. Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998;115:1272-7.
4. Graham DY. Therapy of Helicobacter pylori: current status and issues. Gastroenterology 2000;118:S2-8.
5. Gisbert JP, Pajares JM. Review article. Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment. Aliment Pharmacol Ther 2002;16:1203-8.
6. Lerang F, Moum B, Ragnhildstveit E, et al. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective, randomized 1-year follow-up study. Am J Gastroenterol 1997;92:653-8.
7. Dore MP, Graham DY, Mele R, et al. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Am J Gastroenterol 2002;97:857-60.
8. Graham DY, Hoffman J, El-Zimaity HMT, et al. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11:935-8.